Clinical Utility of Urinary Monocyte Chemoattractant Protein- 1 (MCP-1) Assay in Lupus Nephritis Patients
Saadeya Mosa Mosa Mohammed;
Abstract
Summary
LN is a prominent feature in SLE, present in 15–30% of patients with lupus at the time of initial diagnosis and 30–50% during disease progression. Present assessment of SLE patients includes a urinalysis, creatinine clearance and measurement of u
LN is a prominent feature in SLE, present in 15–30% of patients with lupus at the time of initial diagnosis and 30–50% during disease progression. Present assessment of SLE patients includes a urinalysis, creatinine clearance and measurement of u
Other data
| Title | Clinical Utility of Urinary Monocyte Chemoattractant Protein- 1 (MCP-1) Assay in Lupus Nephritis Patients | Other Titles | الأهمية الإكلينيكية لقياس بروتين وحيدات الإنجذاب الكيميائي للخلية وحيدة النواة البولي لمرضى الإلتهاب الكلوي الذئبي | Authors | Saadeya Mosa Mosa Mohammed | Keywords | Clinical Utility of Urinary Monocyte Chemoattractant Protein- 1 (MCP-1) Assay in Lupus Nephritis Patients | Issue Date | 2011 | Description | Summary LN is a prominent feature in SLE, present in 15–30% of patients with lupus at the time of initial diagnosis and 30–50% during disease progression. Present assessment of SLE patients includes a urinalysis, creatinine clearance and measurement of u |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.